Form 4 for PCVX Vaxcyte, Inc.
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-02 · accession 0001209191-23-051898 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-10-04 | 2023-10-02 | PCVX | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | S - Sale+OE | $50.40 | -20.0K | 32.5K | -38% | -$1.01M |
| D | 2023-10-04 | 2023-10-02 | PCVX | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | M - OptEx | $21.41 | +20.0K | 40.5K | +98% | +$428.2K |
| D | 2023-10-04 | 2023-10-02 | PCVX | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | M - OptEx | $0.00 | +20.0K | 205.0K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-02 | S | D | 7,134 | $51.44 | 20,487 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $50.97 to $51.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-10-02 | S | D | 4,874 | $50.22 | 27,621 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $49.94 to $50.675. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-10-02 | S | D | 7,992 | $49.58 | 32,495 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $48.94 to $49.93. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2023-10-02 | M | A | 20,000 | $21.41 | 40,487 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2023-10-02 | M | A | 20,000 | $0.00 | 205,000 | D | $21.41 · — to 2032-05-08 | 20,000 Common Stock | (F5) 1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |